David Y. Barefield's lab focuses on understanding the function of the heart's atrial region, which plays a vital role in overall cardiac health. They are investigating how specific proteins that are unique to the atria impact heart function, particularly in conditions like cardiomyopathy. By modeling genetic mutations associated with heart disease in lab-grown cells, they aim to reveal mechanisms underlying atrial dysfunction and its contribution to broader heart problems.

Dr. Seth Robia's research lab at Loyola University Chicago focuses on the regulation of calcium transport in heart cells. The lab studies how small proteins called micropeptides influence the function of calcium pumps in the heart, leading to better understanding of heart problems such as heart failure. Through various experimental techniques, they investigate the mechanisms by which proteins interact and how these interactions change in health and disease.

Dr. Toni R. Pak's lab at Loyola University Chicago explores the relationship between estrogen and microRNA expression in the context of Alzheimer's disease, particularly how these factors differ between sexes. The lab investigates how estrogen influences the regulation and stability of microRNAs in women's brains as they age, with the goal of uncovering mechanisms that could lead to better treatments for Alzheimer's disease.

Dr. Jonathan A. Kirk's lab focuses on understanding the mechanics of heart diseases, particularly how misfolded proteins affect heart function. They aim to improve our knowledge of protein quality control in heart muscle cells, which could lead to new treatments for heart failure. The lab utilizes advanced techniques to visualize how these protein issues arise in healthy and diseased hearts.

Dr. Aleksey V Zima's lab at Loyola University Chicago focuses on understanding how oxidative stress affects the heart's calcium regulation, particularly through the dysfunction of a key protein called the ryanodine receptor. This research aims to uncover the molecular mechanisms behind cardiac issues, especially during conditions like myocardial infarction, which is critical for developing new therapies that can improve heart health. The lab uses advanced genetic models and pharmacological approaches to explore potential treatments for heart diseases.